CGC Canopy Growth Corp
Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1737927 · Reporting currency CAD · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: CAD | 2027Q22026-09-30 | 2026Q12026-06-30 | 2026Q4*2026-03-31 | 2026Q32025-12-31 | 2026Q22025-09-30 | 2026Q12025-06-30 | 2025Q4*2025-03-31 | 2025Q32024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 81.37M | 81.17M | 71.25M | 74.54M | 66.68M | 72.13M | 65.03M | 74.76M |
| Cost of revenue | 58.02M | 58.93M | 62.98M | 53.08M | 44.78M | 54.10M | 54.49M | 50.66M |
| Gross profit | 23.36M | 22.24M | 8.26M | 21.47M | 21.91M | 18.04M | 10.54M | 24.10M |
| SG&A expense | 39.69M | 40.22M | 41.14M | 44.44M | 36.30M | 38.11M | 38.45M | 41.48M |
| Operating income | -22.96M | -22.11M | -95.79M | -26.35M | -16.89M | -22.62M | -18.27M | -23.82M |
| Interest expense | 13.02M | 12.68M | 12.31M | 7.34M | 8.80M | 9.74M | 15.38M | 16.77M |
| Pretax income | -41.49M | -14.71M | -155.57M | -57.98M | -4.76M | -44.57M | -196.34M | -97.77M |
| Income tax | -800,000 | -129,000 | -850,000 | 368,000 | 214,000 | 291,000 | 329,000 | 316,000 |
| Net income | -40.69M | -14.58M | -157.12M | -58.34M | -4.98M | -44.86M | -195.96M | -98.08M |
| EBITDA | -17.20M | -16.76M | -91.05M | -21.60M | -12.12M | -17.87M | -12.32M | -18.88M |
| EPS (basic) | -0.10 | -0.03 | — | -0.17 | -0.02 | -0.24 | — | -0.89 |
| EPS (diluted) | -0.10 | -0.03 | — | -0.17 | -0.02 | -0.24 | — | -0.89 |
| Weighted avg. shares (diluted) | 423.11M | 422.26M | — | 345.53M | 274.03M | 188.32M | — | 110.31M |
| Balance sheet | ||||||||
| Cash & equivalents | 247.34M | 336.62M | 364.68M | 371.32M | 298.06M | 126.20M | 113.81M | 161.91M |
| Short-term investments | 72.45M | — | 0 | 0 | 0 | 17.43M | 17.66M | 16.43M |
| Receivables | 31.74M | 32.55M | 31.24M | 29.00M | 24.56M | 47.97M | 47.51M | 44.39M |
| Inventory | 105.09M | 107.46M | 110.51M | 105.56M | 102.37M | 93.82M | 96.37M | 90.75M |
| Current assets | 480.78M | 506.36M | 529.47M | 524.67M | 445.82M | 303.36M | 294.57M | 341.08M |
| PP&E, net | 304.30M | 311.20M | 316.49M | 285.04M | 288.82M | 291.27M | 293.52M | 299.60M |
| Goodwill | 55.69M | 55.69M | 55.69M | 47.52M | 48.24M | 47.38M | 46.04M | 44.09M |
| Intangibles | 85.48M | 88.48M | 92.41M | 76.17M | 81.15M | 84.33M | 87.20M | 89.79M |
| Total assets | 1.06B | 1.10B | 1.12B | 1.11B | 1.07B | 904.67M | 917.70M | 1.16B |
| Current liabilities | 170.61M | 166.75M | 158.44M | 109.33M | 96.42M | 110.65M | 103.05M | 130.50M |
| Short-term debt | 43.13M | 28.82M | 16.24M | 0 | 1.85M | 6.31M | 4.26M | 3.17M |
| Long-term debt | 202.73M | 211.38M | 217.12M | 224.99M | 226.33M | 289.00M | 299.81M | 438.40M |
| Total debt | 245.86M | 240.20M | 233.36M | 224.99M | 228.18M | 295.30M | 304.07M | 441.57M |
| Total liabilities | 407.48M | 415.29M | 421.14M | 359.06M | 349.14M | 427.68M | 439.13M | 606.22M |
| Shareholders' equity | 650.32M | 688.63M | 697.59M | 747.13M | 720.69M | 477.00M | 478.57M | 558.00M |
| Net debt | -1.48M | -96.42M | -131.32M | -146.33M | -69.88M | 169.10M | 190.26M | 279.66M |
| Shares outstanding | 423.35M | 423.02M | 422.07M | 368.28M | 332.38M | 205.15M | 183.87M | 129.15M |
| Cash flow statement | ||||||||
| Operating cash flow | -12.57M | -25.01M | -18.25M | -17.24M | -17.98M | -10.34M | -33.15M | -26.97M |
| Capital expenditure | 2.98M | 737,000 | 1.00M | 1.80M | 1.23M | 1.31M | 3.09M | 1.22M |
| Free cash flow | -15.55M | -25.75M | -19.25M | -19.04M | -19.20M | -11.64M | -36.24M | -28.18M |
| Investing cash flow | -75.17M | -737,000 | -42.65M | 5.27M | 16.73M | -705,000 | -1.00M | -14.79M |
| Financing cash flow | -498,000 | -7.47M | 46.61M | 91.34M | 169.00M | 25.46M | -15.96M | -30.10M |
| Depreciation & amortization | 5.76M | 5.35M | 4.75M | 4.75M | 4.78M | 4.75M | 5.95M | 4.94M |
| Stock-based compensation | 4.03M | 1.36M | 1.47M | 888,000 | 2.01M | -99,000 | -18.74M | 5.16M |
Free plan shows the latest 8 periods; Pro shows all 34 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.